ACERUS PHARMACEUTICALS CORP has a total of 16 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2012. It filed its patents most often in Japan, Taiwan and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are ASARINA PHARMA AB, JINA PHARMACEUTICALS INC and CLARUS THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 4 | |
#2 | Taiwan | 2 | |
#3 | United States | 2 | |
#4 | Uruguay | 2 | |
#5 | Argentina | 1 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Bryson Nathan | 10 |
#2 | Sharma Avinash Chander | 6 |
#3 | Sharma Avinash | 4 |
#4 | Siobhan Fogarty | 4 |
#5 | Wayne Kreppner | 4 |
#6 | Werner Oberegger | 4 |
#7 | Paul Jose Pierre Marie Maes | 4 |
#8 | Oberegger Werner | 2 |
#9 | Kreppner Wayne | 2 |
#10 | Fogarty Siobhan | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019211668A2 | Neurosteroid derivatives and uses thereof | |
TW201801721A | Nasal cannabinoid compositions | |
US2016250228A1 | Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |